2017 American Transplant Congress
Simultaneous Liver-Kidney Transplants Using Donation After Cardiac Death Donors Long Term Outcomes Not Inferior to Brain Dead Donors.
University of Maryland School of Medicine, Baltimore, MD
Background:The Simultaneous use of both Liver and Kidney from the same DCD donor has become controversial with some authors advocating that DCD organs should not…2017 American Transplant Congress
Long Wait Time Regions for Liver Transplantation for HCC Have a Higher Cumulative Incidence of Death.
Abdominal Transplantation, University of Southern California, Los Angeles, CA
Purpose: To determine the effect of regional variability in wait timeon survival of patients with hepatocellular carcinoma(HCC) listed for deceased donor liver transplantation(DDLT).Methods: Patients age>18…2017 American Transplant Congress
Post-Donation Experiences of Non-Directed (Altruistic) Living Kidney Donors in the United States.
A. Non-directed donors (NDDs) can potentially help alleviate the overburdened kidney transplant waiting list while also improve the quality of life for patients with end-stage…2017 American Transplant Congress
The Relationship Between Frailty and Decreased Physical Performance with Death on the Kidney Transplant Waiting List.
Background: Frailty and decreased physical performance are associated with poor outcomes after kidney transplant. Less is known about their relationship with pre-transplant outcomes. The aim…2017 American Transplant Congress
When Does the Learning Curve End? A High-Volume Single Center Experience with Laparoscopic Donor Nephrectomy Over 16 Years.
Purpose: No studies for any type of surgery have examined learning curves beyond a decade or 100 cases because surgeon turnover and lack of complete…2017 American Transplant Congress
Risk Prediction Model for Delayed Graft Function in a Cohort of Brazilian Kidney Transplantation from Deceased Donors: What You See Is Not What You Get.
1Hospital Geral de Fortaleza, Fortaleza, Brazil; 2Federal University of Ceara, Fortaleza, Brazil
Introduction: The estimated frequency of delayed graft function (DGF) in Brazil ranges from 50 to 70%, despite deceased donor and recipient characteristics similar to those…2017 American Transplant Congress
Alemtuzumab Induction Is Safe, and Permits the Avoidance of Steroids in the Majority of Renal Transplant Recipients.
IntroductionThe introduction of alemtuzumab into routine clinical use has been hindered by safety concerns surrounding its prolonged effect on the lymphoid compartment. Here we report…2017 American Transplant Congress
Acute Renal Replacement Therapy in Pediatric Liver Transplantation: A Predictor of Increased Risk.
1Surgery, UCLA, Los Angeles, CA; 2Pediatric Gastroenterology, UCLA, Los Angeles, CA
BackgroundAmong pediatric patients (≤18 yrs) awaiting liver transplantation (LT), limited data exist on the prognostic significance of acute (<90d) renal replacement therapy (RRT) prior to…2017 American Transplant Congress
Outcomes After Cholecystectomy in Patients with End Stage Renal Disease.
INTRODUCTION: Patients awaiting kidney transplantation are at an increased risk of cholelithiasis and cholecystitis secondary to physiologic changes related to renal failure. Previous studies of…2017 American Transplant Congress
Serva NB1 versus Vitacyte Collagenase: Comparable Human Islet Isolation Outcomes Using DCD Donor Pancreas in China.
Transplant Center, Tianjin First Center Hospital, Tianjin, China
Objective This study was designed to retrospectively compare the effect of Serva NB1 collagenase between Vitacyte collagenase on islet isolation of DCD pancreas in China.…
- « Previous Page
- 1
- …
- 111
- 112
- 113
- 114
- 115
- …
- 155
- Next Page »